脑脊液VDRL试验生物学假阳性在神经梅毒诊断中的病例对照研究
该回顾性病例对照研究在新加坡中央医院免疫与血清学实验室3年内共检测1254份脑脊液VDRL标本,其中53例患者VDRL-CSF阳性,42例(79.2%)为真阳性,11例(20.8%)为生物学假阳性。阳性非螺旋体血清学对真阳性VDRL-CSF的灵敏度为97.6%、特异度100%、阳性预测值100%、阴性预测值91.7%。HIV血清阳性是真阳性VDRL-CSF的独立预测因素。结论认为在未先建立梅毒血清学诊断的情况下检测时,VDRL-CSF生物学假阳性常见,建议脑脊液评估前先进行血清学检测。
要点
- 脑脊液VDRL阳性患者中约两成为生物学假阳性,需结合TPPA-CSF和LIA-CSF IgG确认。
- 阳性非螺旋体血清学对真阳性VDRL-CSF的灵敏度97.6%、特异度100%。
- HIV血清阳性是真阳性VDRL-CSF的独立预测因素。
核心结论
- 在未先建立梅毒血清学诊断的情况下检测时,脑脊液VDRL生物学假阳性常见。
- 建议脑脊液评估前先进行梅毒血清学检测。
研究设计与样本
- 回顾性病例对照研究,纳入新加坡中央医院免疫与血清学实验室3年内接收的脑脊液VDRL检测标本。
- 共1254份标本接受VDRL-CSF检测,其中53例患者VDRL-CSF阳性。
主要发现
- 53例VDRL-CSF阳性患者中42例(79.2%)为真阳性,11例(20.8%)为假阳性。
- 阳性非螺旋体血清学对真阳性VDRL-CSF的灵敏度97.6%、特异度100%、阳性预测值100%、阴性预测值91.7%。
- HIV血清阳性是真阳性VDRL-CSF的独立预测因素。
关键数值与推荐
- 生物学假阳性VDRL-CSF定义为VDRL-CSF反应性且TPPA-CSF无反应性和/或LIA-CSF IgG阴性。
- 真阳性VDRL-CSF定义为VDRL-CSF反应性且TPPA-CSF一致反应性和/或LIA-CSF IgG阳性。
临床怎么用
- 脑脊液VDRL检测前应先完成梅毒血清学诊断。
- VDRL-CSF阳性时需结合TPPA-CSF和LIA-CSF IgG确认,避免将生物学假阳性误判为神经梅毒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is no clear consensus on the diagnosis of neurosyphilis. The Venereal Disease Research Laboratory (VDRL) test from cerebrospinal fluid (CSF) has traditionally been considered the gold standard for diagnosing neurosyphilis but is widely known to be insensitive. OBJECTIVE: In this study, we compared the clinical and laboratory characteristics of true-positive VDRL-CSF cases with biological false-positive VDRL-CSF cases. METHODS: We retrospectively identified cases of true and false-positive VDRL-CSF across a 3-year period received by the Immunology and Serology Laboratory, Singapore General Hospital. A biological false-positive VDRL-CSF is defined as a reactive VDRL-CSF with a non-reactive Treponema pallidum particle agglutination (TPPA)-CSF and/or negative Line Immuno Assay (LIA)-CSF IgG. A true-positive VDRL-CSF is a reactive VDRL-CSF with a concordant reactive TPPA-CSF and/or positive LIA-CSF IgG. RESULTS: During the study period, a total of 1254 specimens underwent VDRL-CSF examination. Amongst these, 60 specimens from 53 patients tested positive for VDRL-CSF. Of the 53 patients, 42 (79.2%) were true-positive cases and 11 (20.8%) were false-positive cases. In our setting, a positive non-treponemal serology has 97.6% sensitivity, 100% specificity, 100% positive predictive value and 91.7% negative predictive value for a true-positive VDRL-CSF based on our laboratory definition. HIV seropositivity was an independent predictor of a true-positive VDRL-CSF. CONCLUSION: Biological false-positive VDRL-CSF is common in a setting where patients are tested without first establishing a serological diagnosis of syphilis. Serological testing should be performed prior to CSF evaluation for neurosyphilis.
引用
- Zheng S, Lin RJ, Chan YH, et al. Biological false-positive venereal disease research laboratory test in cerebrospinal fluid in the diagnosis of neurosyphilis - a case-control study. J Eur Acad Dermatol Venereol. 2017. PMID: 29117430. doi:10.1111/jdv.14681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。